Ligand.com

Site Inspections

Overview & More informations

Ligand Pharmaceuticals (NASDAQ: LGND) is a biopharmaceutical company focused on the development and commercialization of therapies for unmet medical needs. The company's portfolio includes therapies for hematology/oncology, metabolic diseases, and rare diseases. Ligand's key products include Promacta (eltrombopag), Kyprolis (carfilzomib), and Tpoxx (tecovirimat). The company also has a number of promising pipeline candidates in development, including several that are in late-stage clinical trials.

Ligand is headquartered in San Diego, California, and has operations in the United States, Europe, and Asia. The company employs approximately 500 people worldwide. Ligand's website is https://www.ligand.com/.

The company's website provides a wealth of information about its products, pipeline, and financial performance. The site also includes a section for investors, which provides access to financial reports, SEC filings, and other relevant documents.

In addition to its website, Ligand also maintains a presence on social media. The company has accounts on Twitter, LinkedIn, and Facebook. These accounts provide updates on the company's latest news and events, as well as links to additional information about Ligand.

Overall, Ligand Pharmaceuticals is a well-established biopharmaceutical company with a strong portfolio of products and a promising pipeline of development candidates. The company's website and social media presence provide a valuable resource for investors and other stakeholders who are interested in learning more about Ligand.

Domains Expiration Date Updated